These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 9272507

  • 1. Molecular biology of the long QT syndrome: impact on management.
    Priori SG, Napolitano C, Paganini V, Cantù F, Schwartz PJ.
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [Abstract] [Full Text] [Related]

  • 2. A molecular basis for the therapy of the long QT syndrome.
    Priori SG, Napolitano C, Schwartz PJ.
    Arch Mal Coeur Vaiss; 1996 Sep; 89(9):1185-7. PubMed ID: 8952843
    [Abstract] [Full Text] [Related]

  • 3. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
    Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantù F, Towbin JA, Keating MT, Hammoude H, Brown AM, Chen LS, Colatsky TJ.
    Circulation; 1995 Dec 15; 92(12):3381-6. PubMed ID: 8521555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome.
    Priori SG, Napolitano C, Cantù F, Brown AM, Schwartz PJ.
    Circ Res; 1996 Jun 15; 78(6):1009-15. PubMed ID: 8635231
    [Abstract] [Full Text] [Related]

  • 6. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
    Sicouri S, Antzelevitch D, Heilmann C, Antzelevitch C.
    J Cardiovasc Electrophysiol; 1997 Nov 15; 8(11):1280-90. PubMed ID: 9395171
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
    Shimizu W, Antzelevitch C.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):778-86. PubMed ID: 10716483
    [Abstract] [Full Text] [Related]

  • 8. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W, Antzelevitch C.
    Circulation; 1997 Sep 16; 96(6):2038-47. PubMed ID: 9323097
    [Abstract] [Full Text] [Related]

  • 9. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
    Bos JM, Crotti L, Rohatgi RK, Castelletti S, Dagradi F, Schwartz PJ, Ackerman MJ.
    Circ Arrhythm Electrophysiol; 2019 May 16; 12(5):e007280. PubMed ID: 31006312
    [Abstract] [Full Text] [Related]

  • 10. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W, Antzelevitch C.
    Circulation; 2000 Aug 08; 102(6):706-12. PubMed ID: 10931813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sodium channel blockers in the management of long QT syndrome types 3 and 2: A system review and meta-analysis.
    Yang Y, Lv TT, Li SY, Zhang P.
    J Cardiovasc Electrophysiol; 2021 Nov 08; 32(11):3057-3067. PubMed ID: 34427958
    [Abstract] [Full Text] [Related]

  • 13. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
    Shimizu W, Antzelevitch C.
    J Electrocardiol; 1999 Nov 08; 32 Suppl():177-84. PubMed ID: 10688323
    [Abstract] [Full Text] [Related]

  • 14. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
    Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L.
    J Am Coll Cardiol; 1999 Sep 08; 34(3):823-9. PubMed ID: 10483966
    [Abstract] [Full Text] [Related]

  • 15. Genetics, molecular mechanisms and management of long QT syndrome.
    Wang Q, Chen Q, Towbin JA.
    Ann Med; 1998 Feb 08; 30(1):58-65. PubMed ID: 9556090
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.